MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1111/1471-0528.18146

Медицинская библиотека · BJOG : an international journal of obstetrics and gynaecology · 2025

Propranolol and Oxytocin-Induced Contractility in Gravid Human Myometrium: An Ex Vivo Laboratory Study.

Balki Mrinalini, Miller Lauren M, Caliaperumal Jayalakshmi, Wang Stella, Huszti Ella, Kingdom John C

Клиническое исследованиеСтатьяПеревод пока не подготовлен

Аннотация

OBJECTIVE

To determine the effect of propranolol on myometrial contractions induced by low dose and high dose oxytocin.

DESIGN

Prospective ex vivo laboratory study.

SETTING

Mount Sinai Hospital, Toronto.

POPULATION: Full-term parturients who underwent elective caesarean deliveries (CD).

METHODS

Two models were developed in the organ bath chamber using myometrial samples obtained during CDs: (i) Labor induction-augmentation model with low-dose oxytocin consisting of 3 groups with the administration of propranolol before and during simulated labor, and a control group. (ii) Postpartum haemorrhage (PPH) model with high-dose oxytocin consisting of 4 groups with the administration of propranolol during and/or after augmented labor (desensitised with oxytocin), and a control group.

MAIN OUTCOME MEASURES: Myometrial contractility was recorded using force transducers.

RESULTS

In the labor induction-augmentation model, propranolol pre-treatment produced a higher area under the curve (AUC) of myometrial contractility induced by low-dose oxytocin (relative percentage difference [diff]: 20.4%; 95% CI [1.4%, 43.2%], p = 0.035) compared to control; however, no difference was observed when propranolol was given after the initiation of labor. In the oxytocin-desensitised PPH model, the AUC of myometrial contractility induced by high-dose oxytocin was improved with propranolol pre-treatment (diff 25.4% [0.2%, 56.8%], p = 0.048), co-treatment (diff 26.7% [3.7%, 54.7%], p = 0.02), and both pre- and co-treatment (diff 28.4% [7.0%, 54.1%], p = 0.007) when compared to the control group.

CONCLUSIONS

Our ex vivo study suggests that propranolol can augment uterine activity by approximately 20%-25% when administered early during labor induction and augmentation. Clinical studies are warranted to determine the relevance of these findings in vivo.

TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT03434444; https://clinicaltrials.gov/.

Для цитирования: Balki Mrinalini, Miller Lauren M, Caliaperumal Jayalakshmi, Wang Stella, Huszti Ella, Kingdom John C. Propranolol and Oxytocin-Induced Contractility in Gravid Human Myometrium: An Ex Vivo Laboratory Study.. BJOG : an international journal of obstetrics and gynaecology. 2025. DOI: 10.1111/1471-0528.18146.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.